臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yeh p y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 106-130 / 177 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-26T03:25:57Z	Angiopoietin-2-induced arterial stiffness in CKD	Chang F.-C.;Chiang W.-C.;Tsai M.-H.;Yu-Hsiang Chou;Pan S.-Y.;Chang Y.-T.;Yeh P.-Y.;Chen Y.-T.;Chiang C.-K.;Chen Y.-M.;Chu T.-S.;Wu K.-D.;Lin S.-L.; Chang F.-C.; Chiang W.-C.; Tsai M.-H.; YU-HSIANG CHOU; Pan S.-Y.; Chang Y.-T.; Yeh P.-Y.; Chen Y.-T.; Chiang C.-K.; Chen Y.-M.; Chu T.-S.; Wu K.-D.; Lin S.-L.
臺大學術典藏	2020-05-26T03:25:54Z	Erythropoietin modulates macrophages but not post-ischemic acute kidney injury in mice	Yeh P.-Y.; Liu C.-H.; Shih H.-M.; Chang F.-C.; Chiang W.-C.; Chu T.-S.; Lin S.-L.; Yu-Hsiang Chou;Liao F.-L.;Chen Y.-T.;Yeh P.-Y.;Liu C.-H.;Shih H.-M.;Chang F.-C.;Chiang W.-C.;Chu T.-S.;Lin S.-L.; YU-HSIANG CHOU; Liao F.-L.; Chen Y.-T.
臺大學術典藏	2020-05-25T06:52:11Z	Basal levels and patterns of anticancer drug-induced activation of nuclear factor-�eB (NF-�eB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells	Cheng A.-L.;Gao M;Liao C.-M;Lai G.-M;Yen-Shen Lu;Yeh P.-Y;Chuang S.-E; Chuang S.-E; Yeh P.-Y; YEN-SHEN LU; Lai G.-M; Liao C.-M; Gao M; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:08Z	Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-�eB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa	Yen-Shen Lu;Yeh P.-Y;Chuang S.-E;Gao M;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Yeh P.-Y; Chuang S.-E; Gao M; Kuo M.-L; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:08Z	Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors	Kuo M.-L; Kuo S.-H; Cheng A.-L.; Yeh K.-H; Yeh P.-Y; Lien H.-C; YEN-SHEN LU; Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Yeh K.-H;Kuo M.-L;Kuo S.-H;Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:07Z	Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity	Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Kuo S.-H;Chang W.-C;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Lien H.-C; Yeh P.-Y; Kuo S.-H; Chang W.-C; Kuo M.-L; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:05Z	NF-�eB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells	Cheng A.-L.;Kuo M.-L;Chang W.C;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Chang W.C; Kuo M.-L; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:04Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen P.-J; Cheng A.-L.; Hsieh H.-P; YEN-SHEN LU; Hsu C.-H; Hsu C; Yeh P.-Y; Cheng A.-L.;Chen P.-J;Hsieh H.-P;Yen-Shen Lu;Hsu C.-H;Hsu C;Yeh P.-Y;Chen K.-F; Chen K.-F
臺大學術典藏	2020-05-25T06:52:04Z	OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma	Cheng A.-L.;Kuo M.-L;Chen C.-S;Feng W.-C;Lee W.-C;Chen K.-F;Hsu C.-H;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Hsu C.-H; Chen K.-F; Lee W.-C; Feng W.-C; Chen C.-S; Kuo M.-L; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:01Z	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:00Z	I�eB kinases increase Myc protein stability and enhance progression of breast cancer cells	Yeh P.-Y;Yen-Shen Lu;Ou D.-L;Cheng A.-L.; Yeh P.-Y; YEN-SHEN LU; Ou D.-L; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:00Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Kuo S.-H;Hsu C.-H;Chen L.-T;Yen-Shen Lu;Lin C.-H;Yeh P.-Y;Jeng H.-J;Gao M;Yeh K.-H;Cheng A.-L.; Kuo S.-H; Hsu C.-H; Chen L.-T; YEN-SHEN LU; Lin C.-H; Yeh P.-Y; Jeng H.-J; Gao M; Yeh K.-H; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:38Z	Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin	Chih-Hung Hsu;Hergenhahn M.;Chuang S.-E.;Yeh P.-Y.;Wu T.-C.;Gao M.;Cheng A.-L.; CHIH-HUNG HSU; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:37Z	Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy	Chih-Hung Hsu;Hsu H.-C.;Chen H.-L.;Gao M.;Yeh P.-Y.;Chen P.-J.;Cheng A.-L.; CHIH-HUNG HSU; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:27Z	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Kuo S.-H.;Chih-Hung Hsu;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; CHIH-HUNG HSU; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:26Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Kuo S.-H.; CHIH-HUNG HSU; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. ;Chih-Hung Hsu ;Chen L.-T. ;Lu Y.-S. ;Lin C.-H. ;Yeh P.-Y. ;Jeng H.-J. ;Gao M. ;Yeh K.-H. ;Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:21Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; Chiun Hsu; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:21Z	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	Lin Z.-Z.;Hsu H.-C.;Hsu C.-H.;Yeh P.-Y.;Huang C.-Y.F.;Huang Y.-F.;Chen T.-J.;Kuo S.-H.;Chiun Hsu;Hu F.-C.;Jeng Y.-M.;Chung Y.;Cheng A.-L.; Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Chiun Hsu; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:17Z	Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells	Shen Y.-C.; Ou D.-L.; Ou D.-L.;Shen Y.-C.;Yu S.-L.;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Chiun Hsu;Cheng A.-L.; Cheng A.-L.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Chiun Hsu; Chen K.-F.; Yu S.-L.
臺大學術典藏	2020-03-07T06:48:26Z	Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas	Kuo S.-H.;Chen L.-T.;Yeh K.-H.;Wu M.-S.;Hsu H.-C.;Yeh P.-Y.;Tsui-Lien Mao;Chen C.-L.;Doong S.-L.;Lin J.-T.;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; Yeh K.-H.; Wu M.-S.; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO; Chen C.-L.; Doong S.-L.; Lin J.-T.; Cheng A.-L.
臺大學術典藏	2020-03-07T06:42:20Z	Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression	Kuo S.-H.; Chen L.-T.; Wu M.-S.; KUAN-TING KUO; Yeh K.-H.; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; Lin C.-W.; Lin J.-T.; Cheng A.L.
臺大學術典藏	2020-03-07T06:42:19Z	Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment	Kuo S.-H.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; KUAN-TING KUO; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; Cheng A.-L.
臺大學術典藏	2020-03-06T08:25:24Z	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	Cheng A.-L.; Chung Y.; YUNG-MING JENG; Hu F.-C.; Hsu C.; Kuo S.-H.; Chen T.-J.; Huang Y.-F.; Huang C.-Y.F.; Yeh P.-Y.; Hsu C.-H.; Hsu H.-C.; Lin Z.-Z.
臺大學術典藏	2020-03-05T12:32:57Z	Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas	Kuo S.-H.; Chen L.-T.; Yeh K.-H.; Wu M.-S.; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO; Chen C.-L.; Doong S.-L.; Lin J.-T.; Cheng A.-L.
臺大學術典藏	2020-03-05T07:52:41Z	Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment	Kuo S.-H.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; KUAN-TING KUO; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; Cheng A.-L.

顯示項目 106-130 / 177 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52903959 線上人數 : 740 教育部委託研究計畫計畫執行:國立臺灣大學圖書館